This appears to be a major new market for CBD.
Post# of 87254
(Total Views: 462)
Posted On: 07/01/2019 1:41:32 PM
This appears to be a major new market for CBD.
A few cannabis, biotech, and pharmaceutical companies have been developing and testing cannabis-derived oral care solutions from the beginning, aiming to get them on the shelves of drug stores and health food stores as quickly as possible.
Cannabinoid research and product development company, AXIM® Biotechnologies, Inc. (OTC: AXIM), has a history of developing cannabis-derived oral health products through extensive research. The company recently partnered with Impression Healthcare to supply its CBD toothpaste and mouthwash for a clinical periodontitis treatment trial.
They're looking to test the effectiveness of CBD in treating periodontitis, with trials to be performed at Swinburne University of Technology in Melbourne, Australia. The teams are using a patented formula developed by Axim to maximize the presence of CBD in the oral cavity during brushing.
“CBD is a powerful antibiotic and anti-inflammatory, so we have found it has great benefits in relation to oral care after years of offering our patented CBD-based chewing gum,” Axim CEO John W. Huemoeller II related in a written interview. "The inclusion of CBD for anti-inflammatory and antibiotic is intended to aid reduction in gum swelling while helping to eliminate infection-causing bacteria.”
The end game is a new line of CBD oral hygiene products, including toothpaste and mouthwash, for the treatment of symptoms associated with gum disease. Huemoeller cites consumer preferences as key to his company's commitment to develop these products. "They [consumers] are eager to have wider access to safely regulated CBD for their various needs," he believes." Consumer buying trends will heavily shape the currently vast CBD industry as companies see buying trends lean to one type of product or another."
Advances in cannabis-derived oral health research and development paired with this consumer power will only further an already active wave of changing sentiment about cannabis in America. "As CBD comes to light as a health supplement with a range of potential treatments, the FDA is already feeling the pressure from the CBD industry and its consumers to allow the non-psychoactive compound to be added into foods and beverages," Huemoeller said.
https://www.forbes.com/sites/andrebourque/201...af12d830fb
A few cannabis, biotech, and pharmaceutical companies have been developing and testing cannabis-derived oral care solutions from the beginning, aiming to get them on the shelves of drug stores and health food stores as quickly as possible.
Cannabinoid research and product development company, AXIM® Biotechnologies, Inc. (OTC: AXIM), has a history of developing cannabis-derived oral health products through extensive research. The company recently partnered with Impression Healthcare to supply its CBD toothpaste and mouthwash for a clinical periodontitis treatment trial.
They're looking to test the effectiveness of CBD in treating periodontitis, with trials to be performed at Swinburne University of Technology in Melbourne, Australia. The teams are using a patented formula developed by Axim to maximize the presence of CBD in the oral cavity during brushing.
“CBD is a powerful antibiotic and anti-inflammatory, so we have found it has great benefits in relation to oral care after years of offering our patented CBD-based chewing gum,” Axim CEO John W. Huemoeller II related in a written interview. "The inclusion of CBD for anti-inflammatory and antibiotic is intended to aid reduction in gum swelling while helping to eliminate infection-causing bacteria.”
The end game is a new line of CBD oral hygiene products, including toothpaste and mouthwash, for the treatment of symptoms associated with gum disease. Huemoeller cites consumer preferences as key to his company's commitment to develop these products. "They [consumers] are eager to have wider access to safely regulated CBD for their various needs," he believes." Consumer buying trends will heavily shape the currently vast CBD industry as companies see buying trends lean to one type of product or another."
Advances in cannabis-derived oral health research and development paired with this consumer power will only further an already active wave of changing sentiment about cannabis in America. "As CBD comes to light as a health supplement with a range of potential treatments, the FDA is already feeling the pressure from the CBD industry and its consumers to allow the non-psychoactive compound to be added into foods and beverages," Huemoeller said.
https://www.forbes.com/sites/andrebourque/201...af12d830fb
(4)
(0)